MétaCan
Menu
Back to cohort
Record W2131495531 · doi:10.1016/j.juro.2014.02.2079

MP67-12 MRI TARGETED BIOPSY FOR THE DETECTION OF PROSTATE CANCER IN PATIENTS AFTER PRIOR NEGATIVE BIOPSIES.

2014· article· en· W2131495531 on OpenAlexaboutno aff
Hamidreza Abdi, Triona Walshe, Farshad Pourmalek, Silvia D. Chang, Martin Gleave, Alison Harris, Alan So, S. Larry Goldenberg, Lindsay Machan, Peter C. Black

Bibliographic record

VenueThe Journal of Urology · 2014
Typearticle
Languageen
FieldMedicine
TopicRadiomics and Machine Learning in Medical Imaging
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineProstate cancerBiopsyProstate biopsyCancer detectionProstateCancerGeneral surgeryRadiologyInternal medicine

Abstract

fetched live from OpenAlex

You have accessJournal of UrologyProstate Cancer: Detection & Screening IV1 Apr 2014MP67-12 MRI TARGETED BIOPSY FOR THE DETECTION OF PROSTATE CANCER IN PATIENTS AFTER PRIOR NEGATIVE BIOPSIES. Hamidreza Abdi, Triona Walshe, Homi Zargar, Farshad Pourmalek, Silvia D. Chang, Martin E. Gleave, Alison C. Harris, Alan I. So, S Larry Goldenberg, Lindsay Machan, and Peter C. Black Hamidreza AbdiHamidreza Abdi More articles by this author , Triona WalsheTriona Walshe More articles by this author , Homi ZargarHomi Zargar More articles by this author , Farshad PourmalekFarshad Pourmalek More articles by this author , Silvia D. ChangSilvia D. Chang More articles by this author , Martin E. GleaveMartin E. Gleave More articles by this author , Alison C. HarrisAlison C. Harris More articles by this author , Alan I. SoAlan I. So More articles by this author , S Larry GoldenbergS Larry Goldenberg More articles by this author , Lindsay MachanLindsay Machan More articles by this author , and Peter C. BlackPeter C. Black More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.2079AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES As technical advancements improve the ability of multi-parametric MRI (mpMRI) of the prostate to detect clinically significant prostate cancer (CaP) while leaving clinically low risk tumors undiagnosed, the clinical application of mpMRI continues to evolve. We aimed to determine the efficacy of mpMRI in the detection of CaP in patients with prior negative transrectal ultrasound-guided prostate biopsy (TRUSBx). METHODS The study was designed as a non-randomized retrospective cohort study. Between January 2010 and September 2013, 2416 men were identified as having had TRUSBx and/or mpMRI at Vancouver General Hospital. Among these, there was a persistent suspicion of CaP in 283 despite prior negative TRUSBx. An MRI was obtained in 112, and a lesion (PIRADS score ≥ 3) was identified in 88 cases (78%). A subsequent MRI-TRUS fusion biopsy (“cognitive” or software-directed (Hologic Inc., Bedford, MA)) in addition to standard template biopsy (8-12 cores depending on prostate volume), was performed in 86 of these 88 cases. From the 171 men who underwent repeat TRUSBx without MRI, a matching cohort of 86 patients was selected using a one-nearest neighbour method without replacement. Matching was based on PSA level, PSA density, prostate volume, and history of ASAP or HGPIN in previous biopsies. The end-point was the detection rate of any CaP or clinically significant CaP (Gleason ≥3+4). Logistic regression analysis was used to determine which factors predicted significant CaP on fusion biopsy. RESULTS Twenty-six patients with mpMRI but no subsequent biopsy were followed for a mean of 14 months without subsequent diagnosis of prostate cancer. Fusion biopsy detected CaP and clinically significant CaP in 36 (42%) and 30 (35%) of men compared to19 (22%) and 14 (16%), respectively, in the men without MRI (p = 0.006 for both). In 9 cases (10%) fusion biopsy detected significant CaP that was missed on standard cores. Significant CaP was present in 5 cases (6%) on standard cores but not the targeted cores. CONCLUSIONS In patients with prior negative biopsy but persistent concern for prostate cancer, MRI enhances the detection of CaP and especially clinically significant CaP. It is possible that this also reduces the number of patients undergoing TRUSBx, although we are uncertain of the true CaP status in the 23% of patients who underwent mpMRI without subsequent TRUSBx. While these results require further validation, we now routinely obtain mpMRI before second TRUSBx. © 2014FiguresReferencesRelatedDetails Volume 191Issue 4SApril 2014Page: e753 Advertisement Copyright & Permissions© 2014MetricsAuthor Information Hamidreza Abdi More articles by this author Triona Walshe More articles by this author Homi Zargar More articles by this author Farshad Pourmalek More articles by this author Silvia D. Chang More articles by this author Martin E. Gleave More articles by this author Alison C. Harris More articles by this author Alan I. So More articles by this author S Larry Goldenberg More articles by this author Lindsay Machan More articles by this author Peter C. Black More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.052
Threshold uncertainty score0.173

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0520.016

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.005
GPT teacher head0.260
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of UrologySame topicRadiomics and Machine Learning in Medical ImagingFrench-language works237,207